Elecampane (Inula helenium) Root Extract and Its Major Sesquiterpene Lactone, Alantolactone, Inhibit Adipogenesis of 3T3-L1 Preadipocytes

Recent studies have shown that Nur77 and AMPK alpha play an important role in regulating adipogenesis and isoalantolactone (ISO) dual-targeting AMPK alpha and Nur77 inhibits adipogenesis. In this study, we hypothesized that Inula helenium (elecampane) root extract (IHE), which contains two sesquiterpene lactones, alantolactone (ALA) and ISO, as major compounds, might inhibit adipogenesis. Here, we found that ALA and IHE simultaneously target AMPK alpha and Nur77 and inhibited adipogenic differentiation of 3T3-L1 cells, accompanied by the decreased expression of adipocyte markers. Further mechanistic studies demonstrated that IHE shares similar mechanisms of action with ISO that reduce mitotic clonal expansion during the early phase of adipogenic differentiation and decrease expression of cell cycle regulators. These results suggest that IHE inhibits adipogenesis, in part, through co-regulation of AMPK alpha and Nur77, and has potential as a therapeutic option for obesity and related metabolic dysfunction.

Automated summary

This study found that alantolactone (ALA) and Inula helenium (elecampane) root extract (IHE) simultaneously target AMPK alpha and Nur77, inhibiting adipogenic differentiation and reducing the expression of adipocyte markers. Further mechanistic studies revealed that IHE shares similar mechanisms of action with isoalantolactone (ISO), reducing mitotic clonal expansion during early adipogenic differentiation and decreasing expression of cell cycle regulators. These results suggest that IHE inhibits adipogenesis through co-regulation of AMPK alpha and Nur77, and may serve as a therapeutic option for obesity and related metabolic dysfunction.